Frekil Pricing Page

Analysis

Frekil's approach likely emphasizes value delivery through clinical validation rather than seat-based tiers, given that RWD intelligence platforms typically serve research teams with varying data complexity needs. The pricing probably highlights integration capabilities and data processing volume as primary differentiators, reflecting how healthcare organizations evaluate these tools based on real-world data scope rather than user counts. As a YC company targeting clinical workflows, the page would presumably anchor messaging around compliance, data security, and time-to-insight rather than feature lists, since those factors directly impact purchasing decisions in regulated healthcare environments.

Notes

YC Spring 2025. Intelligence Layer for Clinical Real World Data (RWD)